| Year |
Citation |
Score |
| 2015 |
Murtola T, Gurel B, Umbehr M, Lucia MS, Thompson IM, Goodman PJ, Kristal AR, Parnes HL, Lippman SM, Sutcliffe S, Peskoe SB, Barber JR, Drake CG, Nelson WG, De Marzo AM, et al. Inflammation in benign prostate tissue and prostate cancer in the finasteride arm of the Prostate Cancer Prevention Trial. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26715424 DOI: 10.1158/1055-9965.Epi-15-0987 |
0.355 |
|
| 2015 |
Barrington WE, Schenk JM, Etzioni R, Arnold KB, Neuhouser ML, Thompson IM, Lucia MS, Kristal AR. Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Jama Oncology. 1: 342-9. PMID 26181184 DOI: 10.1001/Jamaoncol.2015.0513 |
0.445 |
|
| 2015 |
Hoque A, Yao S, Till C, Kristal AR, Goodman PJ, Hsing AW, Tangen CM, Platz EA, Stanczyk FZ, Reichardt JK, vanBokhoven A, Neuhouser ML, Santella RM, Figg WD, Price DK, et al. Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade disease. Urology. 85: 616-20. PMID 25733274 DOI: 10.1016/J.Urology.2014.11.024 |
0.387 |
|
| 2014 |
Crowe FL, Appleby PN, Travis RC, Barnett M, Brasky TM, Bueno-de-Mesquita HB, Chajes V, Chavarro JE, Chirlaque MD, English DR, Gibson RA, Giles GG, Goodman GE, Henning SM, Kaaks R, ... ... Kristal AR, et al. Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies. Journal of the National Cancer Institute. 106. PMID 25210201 DOI: 10.1093/Jnci/Dju240 |
0.353 |
|
| 2014 |
Schenk JM, Till CA, Tangen CM, Goodman PJ, Song X, Torkko KC, Kristal AR, Peters U, Neuhouser ML. Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1484-93. PMID 25085836 DOI: 10.1158/1055-9965.Epi-13-1340 |
0.473 |
|
| 2014 |
Thompson I, Kristal A, Platz EA. Prevention of prostate cancer: outcomes of clinical trials and future opportunities. American Society of Clinical Oncology Educational Book / Asco. American Society of Clinical Oncology. Meeting. e76-80. PMID 24857150 DOI: 10.14694/EdBook_AM.2014.34.e76 |
0.387 |
|
| 2014 |
Gurel B, Lucia MS, Thompson IM, Goodman PJ, Tangen CM, Kristal AR, Parnes HL, Hoque A, Lippman SM, Sutcliffe S, Peskoe SB, Drake CG, Nelson WG, De Marzo AM, Platz EA. Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 847-56. PMID 24748218 DOI: 10.1158/1055-9965.Epi-13-1126 |
0.343 |
|
| 2014 |
Kristal AR, Till C, Song X, Tangen CM, Goodman PJ, Neuhauser ML, Schenk JM, Thompson IM, Meyskens FL, Goodman GE, Minasian LM, Parnes HL, Klein EA. Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1494-504. PMID 24732629 DOI: 10.1158/1055-9965.Epi-14-0115 |
0.437 |
|
| 2014 |
Kristal AR, Darke AK, Morris JS, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL, Goodman GE, Minasian LM, Parnes HL, Lippman SM, Klein EA. Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk. Journal of the National Cancer Institute. 106: djt456. PMID 24563519 DOI: 10.1093/Jnci/Djt456 |
0.434 |
|
| 2014 |
Platz EA, Tangen CM, Goodman PJ, Till C, Parnes HL, Figg WD, Albanes D, Neuhouser ML, Klein EA, Lucia MS, Thompson IM, Kristal AR. Statin drug use is not associated with prostate cancer risk in men who are regularly screened. The Journal of Urology. 192: 379-84. PMID 24518774 DOI: 10.1016/J.Juro.2014.01.095 |
0.382 |
|
| 2014 |
Kristal AR, Kolar AS, Fisher JL, Plascak JJ, Stumbo PJ, Weiss R, Paskett ED. Evaluation of web-based, self-administered, graphical food frequency questionnaire. Journal of the Academy of Nutrition and Dietetics. 114: 613-21. PMID 24462267 DOI: 10.1016/J.Jand.2013.11.017 |
0.311 |
|
| 2013 |
Brasky TM, Darke AK, Song X, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL, Goodman GE, Minasian LM, Parnes HL, Klein EA, Kristal AR. Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. Journal of the National Cancer Institute. 105: 1132-41. PMID 23843441 DOI: 10.1093/Jnci/Djt174 |
0.375 |
|
| 2013 |
Schenk JM, Hunter-Merrill R, Zheng Y, Etzioni R, Gulati R, Tangen C, Thompson IM, Kristal AR. Should modest elevations in prostate-specific antigen, International Prostate Symptom Score, or their rates of increase over time be used as surrogate measures of incident benign prostatic hyperplasia? American Journal of Epidemiology. 178: 741-51. PMID 23813705 DOI: 10.1093/Aje/Kwt044 |
0.431 |
|
| 2013 |
Hastert TA, Beresford SA, Patterson RE, Kristal AR, White E. Adherence to WCRF/AICR cancer prevention recommendations and risk of postmenopausal breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1498-508. PMID 23780838 DOI: 10.1158/1055-9965.Epi-13-0210 |
0.386 |
|
| 2013 |
Neuhouser ML, Platz EA, Till C, Tangen CM, Goodman PJ, Kristal A, Parnes HL, Tao Y, Figg WD, Lucia MS, Hoque A, Hsing AW, Thompson IM, Pollak M. Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trial. Cancer Prevention Research (Philadelphia, Pa.). 6: 91-9. PMID 23315596 DOI: 10.1158/1940-6207.Capr-12-0250 |
0.366 |
|
| 2012 |
Brasky TM, Crowe FL, Kristal AR. n-3 Fatty acids and prostate cancer risk. The British Journal of Nutrition. 108: 1721. PMID 22906807 DOI: 10.1017/S0007114512003431 |
0.319 |
|
| 2012 |
Kristal AR, Till C, Tangen CM, Goodman PJ, Neuhouser ML, Stanczyk FZ, Chu LW, Patel SK, Thompson IM, Reichardt JK, Hoque A, Platz EA, Figg WD, Van Bokhoven A, Lippman SM, et al. Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1823-32. PMID 22879203 DOI: 10.1158/1055-9965.Epi-12-0695 |
0.46 |
|
| 2012 |
Schenk JM, Calip GS, Tangen CM, Goodman P, Parsons JK, Thompson IM, Kristal AR. Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. American Journal of Epidemiology. 176: 156-63. PMID 22759721 DOI: 10.1093/Aje/Kwr524 |
0.326 |
|
| 2012 |
Navarro SL, Brasky TM, Schwarz Y, Song X, Wang CY, Kristal AR, Kratz M, White E, Lampe JW. Reliability of serum biomarkers of inflammation from repeated measures in healthy individuals. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1167-70. PMID 22564866 DOI: 10.1158/1055-9965.Epi-12-0110 |
0.305 |
|
| 2012 |
Parsons JK, Schenk JM, Arnold KB, Messer K, Till C, Thompson IM, Kristal AR. Finasteride reduces the risk of incident clinical benign prostatic hyperplasia. European Urology. 62: 234-41. PMID 22459892 DOI: 10.1016/J.Eururo.2012.03.007 |
0.414 |
|
| 2012 |
Brasky TM, Potter JD, Kristal AR, Patterson RE, Peters U, Asgari MM, Thornquist MD, White E. Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohort. Cancer Causes & Control : Ccc. 23: 431-44. PMID 22212612 DOI: 10.1007/S10552-011-9891-8 |
0.37 |
|
| 2011 |
Cheng TY, Barnett MJ, Kristal AR, Ambrosone CB, King IB, Thornquist MD, Goodman GE, Neuhouser ML. Genetic variation in myeloperoxidase modifies the association of serum α-tocopherol with aggressive prostate cancer among current smokers. The Journal of Nutrition. 141: 1731-7. PMID 21795425 DOI: 10.3945/Jn.111.141713 |
0.442 |
|
| 2011 |
Tang L, Yao S, Till C, Goodman PJ, Tangen CM, Wu Y, Kristal AR, Platz EA, Neuhouser ML, Stanczyk FZ, Reichardt JK, Santella RM, Hsing A, Hoque A, Lippman SM, et al. Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Carcinogenesis. 32: 1500-6. PMID 21771722 DOI: 10.1093/Carcin/Bgr139 |
0.375 |
|
| 2011 |
Yao S, Till C, Kristal AR, Goodman PJ, Hsing AW, Tangen CM, Platz EA, Stanczyk FZ, Reichardt JK, Tang L, Neuhouser ML, Santella RM, Figg WD, Price DK, Parnes HL, et al. Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study. Cancer Causes & Control : Ccc. 22: 1121-31. PMID 21667068 DOI: 10.1007/S10552-011-9787-7 |
0.394 |
|
| 2011 |
Brasky TM, Kristal AR, Navarro SL, Lampe JW, Peters U, Patterson RE, White E. Specialty supplements and prostate cancer risk in the VITamins and Lifestyle (VITAL) cohort. Nutrition and Cancer. 63: 573-82. PMID 21598177 DOI: 10.1080/01635581.2011.553022 |
0.419 |
|
| 2011 |
Schenk JM, Kristal AR, Arnold KB, Tangen CM, Neuhouser ML, Lin DW, White E, Thompson IM. Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial. American Journal of Epidemiology. 173: 1419-28. PMID 21540324 DOI: 10.1093/Aje/Kwq493 |
0.477 |
|
| 2011 |
Brasky TM, Till C, White E, Neuhouser ML, Song X, Goodman P, Thompson IM, King IB, Albanes D, Kristal AR. Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial. American Journal of Epidemiology. 173: 1429-39. PMID 21518693 DOI: 10.1093/Aje/Kwr027 |
0.467 |
|
| 2011 |
Kristal AR, Till C, Platz EA, Song X, King IB, Neuhouser ML, Ambrosone CB, Thompson IM. Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 638-46. PMID 21335507 DOI: 10.1158/1055-9965.Epi-10-1221 |
0.411 |
|
| 2010 |
Goodman PJ, Tangen CM, Kristal AR, Thompson IM, Lucia MS, Platz EA, Figg WD, Hoque A, Hsing A, Neuhouser ML, Parnes HL, Reichardt JK, Santella RM, Till C, Lippman SM. Transition of a clinical trial into translational research: the prostate cancer prevention trial experience. Cancer Prevention Research (Philadelphia, Pa.). 3: 1523-33. PMID 21149329 DOI: 10.1158/1940-6207.Capr-09-0256 |
0.349 |
|
| 2010 |
Price DK, Chau CH, Till C, Goodman PJ, Baum CE, Ockers SB, English BC, Minasian L, Parnes HL, Hsing AW, Reichardt JK, Hoque A, Tangen CM, Kristal AR, Thompson IM, et al. Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trial. The Journal of Urology. 184: 2297-302. PMID 20952028 DOI: 10.1016/J.Juro.2010.08.005 |
0.46 |
|
| 2010 |
Risk MC, Knudsen BS, Coleman I, Dumpit RF, Kristal AR, LeMeur N, Gentleman RC, True LD, Nelson PS, Lin DW. Differential gene expression in benign prostate epithelium of men with and without prostate cancer: evidence for a prostate cancer field effect. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 5414-23. PMID 20935156 DOI: 10.1158/1078-0432.CCR-10-0272 |
0.327 |
|
| 2010 |
Brasky TM, Velicer CM, Kristal AR, Peters U, Potter JD, White E. Nonsteroidal anti-inflammatory drugs and prostate cancer risk in the VITamins And Lifestyle (VITAL) cohort. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 3185-8. PMID 20935064 DOI: 10.1158/1055-9965.Epi-10-0942 |
0.442 |
|
| 2010 |
Kristal AR, Arnold KB, Neuhouser ML, Goodman P, Platz EA, Albanes D, Thompson IM. Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial. American Journal of Epidemiology. 172: 566-77. PMID 20693267 DOI: 10.1093/Aje/Kwq148 |
0.528 |
|
| 2010 |
Hoque A, Ambrosone CB, Till C, Goodman PJ, Tangen C, Kristal A, Lucia S, Wang Q, Kappil M, Thompson I, Hsing AW, Parnes H, Santella RM. Serum oxidized protein and prostate cancer risk within the Prostate Cancer Prevention Trial. Cancer Prevention Research (Philadelphia, Pa.). 3: 478-83. PMID 20332306 DOI: 10.1158/1940-6207.Capr-09-0201 |
0.365 |
|
| 2010 |
Neuhouser ML, Till C, Kristal A, Goodman P, Hoque A, Platz EA, Hsing AW, Albanes D, Parnes HL, Pollak M. Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Cancer Prevention Research (Philadelphia, Pa.). 3: 279-89. PMID 20179296 DOI: 10.1158/1940-6207.Capr-09-0188 |
0.461 |
|
| 2010 |
Schenk JM, Kristal AR, Neuhouser ML, Tangen CM, White E, Lin DW, Kratz M, Thompson IM. Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. American Journal of Epidemiology. 171: 571-82. PMID 20142396 DOI: 10.1093/Aje/Kwp406 |
0.454 |
|
| 2010 |
Platz EA, Sutcliffe S, De Marzo AM, Drake CG, Rifai N, Hsing AW, Hoque A, Neuhouser ML, Goodman PJ, Kristal AR. Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies. Cancer Causes & Control : Ccc. 21: 847-51. PMID 20135215 DOI: 10.1007/S10552-010-9511-Z |
0.379 |
|
| 2010 |
Kristal AR, Price DK, Till C, Schenk JM, Neuhouser ML, Ockers S, Lin DW, Thompson IM, Figg WD. Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. The Prostate. 70: 584-90. PMID 19938041 DOI: 10.1002/Pros.21092 |
0.436 |
|
| 2009 |
Platz EA, Till C, Goodman PJ, Parnes HL, Figg WD, Albanes D, Neuhouser ML, Klein EA, Thompson IM, Kristal AR. Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 2807-13. PMID 19887582 DOI: 10.1158/1055-9965.Epi-09-0472 |
0.389 |
|
| 2009 |
Neuhouser ML, Barnett MJ, Kristal AR, Ambrosone CB, King IB, Thornquist M, Goodman GG. Dietary supplement use and prostate cancer risk in the Carotene and Retinol Efficacy Trial. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 2202-6. PMID 19661078 DOI: 10.1158/1055-9965.Epi-09-0013 |
0.519 |
|
| 2009 |
Takata Y, Morris JS, King IB, Kristal AR, Lin DW, Peters U. Correlation between selenium concentrations and glutathione peroxidase activity in serum and human prostate tissue. The Prostate. 69: 1635-42. PMID 19623542 DOI: 10.1002/Pros.21012 |
0.304 |
|
| 2009 |
Gong Z, Kristal AR, Schenk JM, Tangen CM, Goodman PJ, Thompson IM. Alcohol consumption, finasteride, and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Cancer. 115: 3661-9. PMID 19598210 DOI: 10.1002/Cncr.24423 |
0.448 |
|
| 2009 |
Schenk JM, Kristal AR, Neuhouser ML, Tangen CM, White E, Lin DW, Thompson IM. Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. The Prostate. 69: 1303-11. PMID 19475640 DOI: 10.1002/Pros.20974 |
0.449 |
|
| 2009 |
Fesinmeyer MD, Gulati R, Zeliadt S, Weiss N, Kristal AR, Etzioni R. Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 808-15. PMID 19258479 DOI: 10.1158/1055-9965.Epi-08-0784 |
0.441 |
|
| 2009 |
Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD, Crawford ED, Goodman GE, Claudio J, ... ... Kristal AR, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Jama. 301: 39-51. PMID 19066370 DOI: 10.1001/Jama.2008.864 |
0.45 |
|
| 2008 |
Thompson IM, Tangen CM, Kristal AR. Prostate-specific antigen: a misused and maligned prostate cancer biomarker. Journal of the National Cancer Institute. 100: 1487-8. PMID 18957671 DOI: 10.1093/jnci/djn368 |
0.312 |
|
| 2008 |
Kristal AR, Schenk JM, Song Y, Arnold KB, Neuhouser ML, Goodman PJ, Lin DW, Stanczyk FZ, Thompson IM. Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial. American Journal of Epidemiology. 168: 1416-24. PMID 18945688 DOI: 10.1093/Aje/Kwn272 |
0.363 |
|
| 2008 |
Neuhouser ML, Schenk J, Song YJ, Tangen CM, Goodman PJ, Pollak M, Penson DF, Thompson IM, Kristal AR. Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial. The Prostate. 68: 1477-86. PMID 18618736 DOI: 10.1002/Pros.20819 |
0.332 |
|
| 2008 |
Song YJ, Kristal AR, Wicklund KG, Cushing-Haugen KL, Rossing MA. Coffee, tea, colas, and risk of epithelial ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 712-6. PMID 18349292 DOI: 10.1158/1055-9965.Epi-07-2511 |
0.418 |
|
| 2008 |
Choi JY, Neuhouser ML, Barnett MJ, Hong CC, Kristal AR, Thornquist MD, King IB, Goodman GE, Ambrosone CB. Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort. Carcinogenesis. 29: 964-70. PMID 18296681 DOI: 10.1093/Carcin/Bgn056 |
0.373 |
|
| 2008 |
Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Goodman P, Penson DF, Thompson IM. Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. American Journal of Epidemiology. 167: 925-34. PMID 18263602 DOI: 10.1093/Aje/Kwm389 |
0.502 |
|
| 2008 |
Song Y, Tangen C, Goodman P, Parnes HL, Lucia MS, Thompson IM, Kristal AR. Finasteride, prostate cancer, and weight gain: evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatment. The Prostate. 68: 281-6. PMID 18163420 DOI: 10.1002/Pros.20637 |
0.459 |
|
| 2008 |
Peters U, Littman AJ, Kristal AR, Patterson RE, Potter JD, White E. Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort. Cancer Causes & Control : Ccc. 19: 75-87. PMID 17943452 DOI: 10.1007/S10552-007-9072-Y |
0.48 |
|
| 2008 |
Gong Z, Agalliu I, Lin DW, Stanford JL, Kristal AR. Cigarette smoking and prostate cancer-specific mortality following diagnosis in middle-aged men. Cancer Causes & Control : Ccc. 19: 25-31. PMID 17906959 DOI: 10.1007/S10552-007-9066-9 |
0.437 |
|
| 2007 |
Lin DW, Neuhouser ML, Schenk JM, Coleman IM, Hawley S, Gifford D, Hung H, Knudsen BS, Nelson PS, Kristal AR. Low-fat, low-glycemic load diet and gene expression in human prostate epithelium: a feasibility study of using cDNA microarrays to assess the response to dietary intervention in target tissues. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 2150-4. PMID 17932364 DOI: 10.1158/1055-9965.Epi-07-0154 |
0.337 |
|
| 2007 |
Neuhouser ML, Barnett MJ, Kristal AR, Ambrosone CB, King I, Thornquist M, Goodman G. (n-6) PUFA increase and dairy foods decrease prostate cancer risk in heavy smokers. The Journal of Nutrition. 137: 1821-7. PMID 17585037 DOI: 10.1093/Jn/137.7.1821 |
0.518 |
|
| 2007 |
Choi JY, Neuhouser ML, Barnett M, Hudson M, Kristal AR, Thornquist M, King IB, Goodman GE, Ambrosone CB. Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1115-20. PMID 17548672 DOI: 10.1158/1055-9965.Epi-07-0040 |
0.379 |
|
| 2007 |
Littman AJ, White E, Kristal AR. Anthropometrics and prostate cancer risk. American Journal of Epidemiology. 165: 1271-9. PMID 17395597 DOI: 10.1093/Aje/Kwm013 |
0.485 |
|
| 2007 |
Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Weiss N, Goodman P, Antvelink CM, Penson DF, Thompson IM. Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. The Journal of Urology. 177: 1395-400; quiz 1591. PMID 17382740 DOI: 10.1016/J.Juro.2006.11.065 |
0.459 |
|
| 2007 |
Gong Z, Agalliu I, Lin DW, Stanford JL, Kristal AR. Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men. Cancer. 109: 1192-202. PMID 17311344 DOI: 10.1002/Cncr.22534 |
0.46 |
|
| 2006 |
Velicer CM, Kristal A, White E. Alcohol use and the risk of prostate cancer: results from the VITAL cohort study. Nutrition and Cancer. 56: 50-6. PMID 17176217 DOI: 10.1207/S15327914Nc5601_7 |
0.33 |
|
| 2006 |
Gong Z, Neuhouser ML, Goodman PJ, Albanes D, Chi C, Hsing AW, Lippman SM, Platz EA, Pollak MN, Thompson IM, Kristal AR. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 1977-83. PMID 17035408 DOI: 10.1158/1055-9965.Epi-06-0477 |
0.383 |
|
| 2006 |
Littman AJ, Kristal AR, White E. Recreational physical activity and prostate cancer risk (United States). Cancer Causes & Control : Ccc. 17: 831-41. PMID 16783611 DOI: 10.1007/S10552-006-0024-8 |
0.412 |
|
| 2006 |
Neuhouser ML, Rock CL, Kristal AR, Patterson RE, Neumark-Sztainer D, Cheskin LJ, Thornquist MD. Olestra is associated with slight reductions in serum carotenoids but does not markedly influence serum fat-soluble vitamin concentrations. The American Journal of Clinical Nutrition. 83: 624-31. PMID 16522910 DOI: 10.1093/Ajcn.83.3.624 |
0.342 |
|
| 2006 |
Kristal AR, Chi C, Tangen CM, Goodman PJ, Etzioni R, Thompson IM. Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase. Cancer. 106: 320-8. PMID 16342294 DOI: 10.1002/Cncr.21603 |
0.389 |
|
| 2006 |
Littman A, White E, Kristal A. Hair Balding and Prostate Cancer Risk American Journal of Epidemiology. 163. DOI: 10.1093/Aje/163.Suppl_11.S111-C |
0.457 |
|
| 2006 |
Littman A, Kristal A, White E. Body Mass Index is Associated with Increased Risk of aggressive and Decreased Risk of Non-aggressive Prostate Cancer American Journal of Epidemiology. 163. DOI: 10.1093/Aje/163.Suppl_11.S111-B |
0.438 |
|
| 2005 |
Kristal AR, Schenk JM. Directions for future epidemiological research in lycopene and prostate cancer risk. The Journal of Nutrition. 135: 2037S-9S. PMID 16046734 |
0.348 |
|
| 2005 |
King IB, Kristal AR, Schaffer S, Thornquist M, Goodman GE. Serum trans-fatty acids are associated with risk of prostate cancer in beta-Carotene and Retinol Efficacy Trial. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 988-92. PMID 15824175 DOI: 10.1158/1055-9965.EPI-04-0517 |
0.318 |
|
| 2005 |
Baillargeon J, Pollock BH, Kristal AR, Bradshaw P, Hernandez J, Basler J, Higgins B, Lynch S, Rozanski T, Troyer D, Thompson I. The association of body mass index and prostate-specific antigen in a population-based study Cancer. 103: 1092-1095. PMID 15668913 DOI: 10.1002/Cncr.20856 |
0.322 |
|
| 2005 |
Lippman SM, Goodman PJ, Klein EA, Parnes HL, Thompson IM, Kristal AR, Santella RM, Probstfield JL, Moinpour CM, Albanes D, Taylor PR, Minasian LM, Hoque A, Thomas SM, Crowley JJ, et al. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Journal of the National Cancer Institute. 97: 94-102. PMID 15657339 DOI: 10.1093/jnci/dji009 |
0.352 |
|
| 2004 |
Solomon CC, White E, Kristal AR, Vaughan T. Melanoma and lifetime UV radiation Cancer Causes and Control. 15: 893-902. PMID 15577291 DOI: 10.1007/S10552-004-1142-9 |
0.31 |
|
| 2004 |
Bermejo C, Kristal AR, Zeliadt SB, Ramsey S, Thompson IM. Localized prostate cancer: Quality of life meets Whitmore's legacy Journal of the National Cancer Institute. 96: 1348-1349. PMID 15367562 DOI: 10.1093/Jnci/Djh282 |
0.35 |
|
| 2004 |
Greenlee H, White E, Patterson RE, Kristal AR. Supplement use among cancer survivors in the Vitamins and Lifestyle (VITAL) study cohort. Journal of Alternative and Complementary Medicine (New York, N.Y.). 10: 660-6. PMID 15353022 DOI: 10.1089/Acm.2004.10.660 |
0.416 |
|
| 2004 |
Neuhouser ML, Kristal AR, Penson DF. Steroid hormones and hormone-related genetic and lifestyle characteristics as risk factors for benign prostatic hyperplasia: Review of epidemiologic literature Urology. 64: 201-211. PMID 15302461 DOI: 10.1016/J.Urology.2004.04.025 |
0.381 |
|
| 2004 |
Kristal AR, Stanford JL. Cruciferous vegetables and prostate cancer risk: Confounding by PSA screening Cancer Epidemiology Biomarkers and Prevention. 13: 1265. PMID 15247142 |
0.35 |
|
| 2004 |
Kristal AR. Vitamin A, retinoids and carotenoids as chemopreventive agents for prostate cancer. The Journal of Urology. 171: S54-8; discussion S5. PMID 14713755 DOI: 10.1097/01.ju.0000107836.08339.0a |
0.339 |
|
| 2004 |
Thompson IM, Albanes D, Basler JW, Crawford ED, Denis LJ, Djavan B, Fleshner N, Johnson-Pais TL, Klein EA, Kristal AR, Lucia MS, Parnes HL, Piazza GA, Platz EA, Pollock BH, et al. First International Conference on Chemoprevention of Prostate Cancer. Overview consensus statement. The Journal of Urology. 171: S3-4. PMID 14713744 DOI: 10.1097/01.Ju.0000107100.06725.51 |
0.334 |
|
| 2004 |
Gunther S, Patterson RE, Kristal AR, Stratton KL, White E. Demographic and health-related correlates of herbal and specialty supplement use Journal of the American Dietetic Association. 104: 27-34. PMID 14702580 DOI: 10.1016/J.Jada.2003.10.009 |
0.402 |
|
| 2004 |
White E, Patterson RE, Kristal AR, Thornquist M, King I, Shattuck AL, Evans I, Satia-Abouta J, Littman AJ, Potter JD. VITamins And Lifestyle cohort study: study design and characteristics of supplement users. American Journal of Epidemiology. 159: 83-93. PMID 14693663 DOI: 10.1093/Aje/Kwh010 |
0.412 |
|
| 2003 |
Satia-Abouta J, Patterson RE, King IB, Stratton KL, Shattuck AL, Kristal AR, Potter JD, Thornquist MD, White E. Reliability and validity of self-report of vitamin and mineral supplement use in the vitamins and lifestyle study American Journal of Epidemiology. 157: 944-954. PMID 12746248 DOI: 10.1093/Aje/Kwg039 |
0.353 |
|
| 2003 |
Satia-Abouta J, Kristal AR, Patterson RE, Littman AJ, Stratton KL, White E. Dietary supplement use and medical conditions: the VITAL study. American Journal of Preventive Medicine. 24: 43-51. PMID 12554023 DOI: 10.1016/S0749-3797(02)00571-8 |
0.303 |
|
| 2002 |
Kristal AR, Lampe JW. Brassica vegetables and prostate cancer risk: A review of the epidemiological evidence Nutrition and Cancer. 42: 1-9. PMID 12235639 DOI: 10.1207/S15327914Nc421_1 |
0.395 |
|
| 2002 |
Kristal AR. Diet and trend in prostate-specific antigen: Inferences for prostate cancer risk Journal of Clinical Oncology. 20: 3570-3571. PMID 12202653 |
0.368 |
|
| 2002 |
Kristal AR, Cohen JH, Qu P, Stanford JL. Associations of energy, fat, calcium, and vitamin D with prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 11: 719-25. PMID 12163324 |
0.366 |
|
| 2002 |
Satia-Abouta J, Patterson RE, Schiller RN, Kristal AR. Energy from fat is associated with obesity in U.S. Men: Results from the prostate cancer prevention trial Preventive Medicine. 34: 493-501. PMID 11969348 DOI: 10.1006/Pmed.2002.1018 |
0.359 |
|
| 2002 |
Rock CL, Thornquist MD, Neuhouser ML, Kristal AR, Neumark-Sztainer D, Cooper DA, Patterson RE, Cheskin LJ. Diet and lifestyle correlates of lutein in the blood and diet. The Journal of Nutrition. 132: 525S-530S. PMID 11880586 DOI: 10.1093/Jn/132.3.525S |
0.364 |
|
| 2002 |
Kristal AR. Brassica vegetables and prostate cancer risk: A review of the epidemiologic evidence Pharmaceutical Biology. 40: 55-58. DOI: 10.1076/phbi.40.7.55.9169 |
0.376 |
|
| 2001 |
Neuhouser ML, Kristal AR, Patterson RE, Goodman PJ, Thompson IM. Dietary supplement use in the prostate cancer prevention trial: Implications for prevention trials Nutrition and Cancer. 39: 12-18. PMID 11588893 DOI: 10.1207/S15327914Nc391_2 |
0.359 |
|
| 2001 |
Neuhouser ML, Patterson RE, Kristal AR, Eldridge AL, Vizenor NC. A brief dietary assessment instrument for assessing target foods, nutrients and eating patterns Public Health Nutrition. 4: 73-78. PMID 11315683 DOI: 10.1079/Phn200045 |
0.31 |
|
| 2001 |
Patterson RE, Kristal AR, Neuhouser ML. Vitamin Supplements and Cancer Risk Cancer Causes & Control. 8: 21-43. DOI: 10.1007/978-1-59259-039-1_2 |
0.423 |
|
| 2000 |
Kristal AR, Cohen JH. Invited commentary: Tomatoes, lycopene, and prostate cancer. How strong is the evidence? American Journal of Epidemiology. 151: 124-130. PMID 10645814 |
0.339 |
|
| 2000 |
Cohen JH, Kristal AR, Stanford JL. Fruit and vegetable intakes and prostate cancer risk Journal of the National Cancer Institute. 92: 61-68. PMID 10620635 DOI: 10.1093/JNCI/92.1.61 |
0.438 |
|
| 1999 |
Neuhouser ML, Kristal AR, McLerran D, Patterson RE, Atkinson J. Validity of short food frequency questionnaires used in cancer chemoprevention trials: Results from the Prostate Cancer Prevention Trial Cancer Epidemiology Biomarkers and Prevention. 8: 721-725. PMID 10744133 |
0.365 |
|
| 1999 |
Kristal AR, Stanford JL, Cohen JH, Wicklund K, Patterson RE. Vitamin and mineral supplement use is associated with reduced risk of prostate cancer Cancer Epidemiology Biomarkers and Prevention. 8: 887-892. PMID 10548317 |
0.384 |
|
| 1999 |
Satia JA, Patterson RE, Herrero R, Jin F, Dai Q, King IB, Chen C, Kristal AR, Prentice RL, Rossing MA. Study of diet, biomarkers and cancer risk in the United States, China and Costa Rica International Journal of Cancer. 82: 28-32. PMID 10360816 DOI: 10.1002/(Sici)1097-0215(19990702)82:1<28::Aid-Ijc6>3.0.Co;2-X |
0.383 |
|
| 1999 |
Rock CL, Thornquist MD, Kristal AR, Patterson RE, Cooper DA, Neuhouser ML, Neumark-Sztainer D, Cheskin LJ. Demographic, dietary and lifestyle factors differentially explain variability in serum carotenoids and fat-soluble vitamins: Baseline results from the sentinel site of the olestra post-marketing surveillance study Journal of Nutrition. 129: 855-864. PMID 10203561 DOI: 10.1093/Jn/129.4.855 |
0.344 |
|
| 1999 |
Tilley BC, Vernon SW, Myers R, Glanz K, Lu M, Hirst K, Kristal AR. The next step trial: Impact of a worksite colorectal cancer screening promotion program Preventive Medicine. 28: 276-283. PMID 10072746 DOI: 10.1006/Pmed.1998.0427 |
0.3 |
|
| 1998 |
Kristal AR, Moe G. False presumptions and continued surprises: How much do we really know about nutritional supplements and cancer risk? Cancer Epidemiology Biomarkers and Prevention. 7: 849-850. PMID 9796627 |
0.323 |
|
| 1998 |
Close DR, Kristal AR, Li S, Patterson RE, White E. Associations of demographic and health-related characteristics with prostate cancer screening in Washington state Cancer Epidemiology Biomarkers and Prevention. 7: 627-630. PMID 9681532 |
0.345 |
|
| 1997 |
Kristal AR, Feng Z, Coates RJ, Oberman A, George V. Associations of race/ethnicity, education, and dietary intervention with the validity and reliability of a food frequency questionnaire: The women's health trial feasibility study in minority populations American Journal of Epidemiology. 146: 856-869. PMID 9384206 DOI: 10.1093/Oxfordjournals.Aje.A009203 |
0.329 |
|
| 1997 |
Patterson RE, White E, Kristal AR, Neuhouser ML, Potter JD. Vitamin supplements and cancer risk: The epidemiologic evidence Cancer Causes and Control. 8: 786-802. PMID 9328202 DOI: 10.1023/A:1018443724293 |
0.362 |
|
| 1997 |
Beresford SA, Curry SJ, Kristal AR, Lazovich D, Feng Z, Wagner EH. A dietary intervention in primary care practice: the Eating Patterns Study. American Journal of Public Health. 87: 610-6. PMID 9146440 DOI: 10.2105/Ajph.87.4.610 |
0.316 |
|
| 1996 |
Patterson RE, Kristal AR, Vliite E. Do beliefs, knowledge, and perceived norms about diet and cancer predict dietary change? American Journal of Public Health. 86: 1394-1400. PMID 8876507 DOI: 10.2105/Ajph.86.10.1394 |
0.376 |
|
| 1995 |
Kristal AR, Patterson RE, Glanz K, Heimendinger J, Hebert JR, Feng ZD, Probart C. Psychosocial Correlates of Healthful Diets: Baseline Results from the Working Well Study Preventive Medicine. 24: 221-228. PMID 7644443 DOI: 10.1006/Pmed.1995.1037 |
0.343 |
|
| 1994 |
Kristal AR, Beresford SAA, Lazovich D. Assessing change in diet-intervention research American Journal of Clinical Nutrition. 59. PMID 8279421 DOI: 10.1093/Ajcn/59.1.185S |
0.374 |
|
| 1994 |
Glanz K, Patterson RE, Kristal AR, Diclemente CC, Heimendinger J, Linnan L, McLerran DF. Stages of Change in Adopting Healthy Diets: Fat, Fiber, and Correlates of Nutrient Intake Health Education &Amp; Behavior. 21: 499-519. PMID 7843980 DOI: 10.1177/109019819402100412 |
0.336 |
|
| 1992 |
Urban N, White E, Anderson GL, Curry S, Kristal AR. Correlates of maintenance of a low-fat diet among women in the Women's Health Trial. Preventive Medicine. 21: 279-91. PMID 1614990 DOI: 10.1016/0091-7435(92)90027-F |
0.304 |
|
| Show low-probability matches. |